Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
40m
Pfizer is said to have dropped RSV candidate from pipeline
Pfizer (PFE) discontinues development of experimental RSV therapy sisunatovir from pipeline in a blow for its $525M ...
ENDPOINTS NEWS
49m
GSK's RSV vaccine Arexvy shows long-term protection in Phase 3 trial
GSK said a dose of its RSV vaccine protected against illness over three years, according to new data presented at the CHEST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Human life expectancy study
To campaign for Harris
Jets fire head coach Saleh
Kemp suspends GA mayor
Sex abuse case dismissed
States sue TikTok
To replace lead water pipes
Israel expands offensive
Richest female musician
Former aide charged
Medical copter crash kills 3
Harris on '60 Minutes'
North Dakota wildfires
Hears ghost gun rule case
Win Nobel Prize in physics
Targeted by a cyberattack
Tickets to climb to $5
US overdose deaths drop
Rwandan virus screening
Settles latest civil lawsuit
SCOTUS denies appeal
Hera mission launched
Ordered to open app store
Florida orders evacuations
Hamas backers sanctioned
Liquidation plan approved
Athlete payments approval
More troops to Ukraine?
Intel defensive briefings rise
Related topics
Pfizer
GlaxoSmithKline
Arexvy
Feedback